Antacids Market - By Drug Class (Proton Pump Inhibitors, Acid Neutralizers, Anti-H. Pyloric Drugs), Indication (Gastroesophageal Reflux Disease, Heartburn, Gastritis), Dosage, Route of Administration, Distribution Channel – Global Forecast (2024 – 2032)

Antacids Market - By Drug Class (Proton Pump Inhibitors, Acid Neutralizers, Anti-H. Pyloric Drugs), Indication (Gastroesophageal Reflux Disease, Heartburn, Gastritis), Dosage, Route of Administration, Distribution Channel – Global Forecast (2024 – 2032)

Global Antacids Market size will expand at a 5.1% CAGR between 2024 and 2032, attributed to advances in formulation and delivery methods. Innovations such as chewable tablets, fast-dissolving powders, and convenient liquid forms enhance the effectiveness and user experience of antacids. Furthermore, greater awareness about digestive health and the heightened rate of digestive disorders encourages consumers to seek effective over-the-counter solutions. This combination of technological improvements and increased health consciousness contributes to a rising demand for diverse and advanced antacid products, fueling market expansion.

For instance, in June 2024, Akums Drugs & Pharmaceuticals Ltd. launched a new anti-reflux chewable tablet containing sodium alginate and potassium bicarbonate, which has been approved by the Drugs Controller General of India (DCGI). This innovation reflects growing advancements in antacid formulations, catering to the increasing demand for effective, user-friendly digestive solutions. The approval highlights the rising regulatory support for new antacid products, while the introduction of such advanced formulations can drive market growth by offering enhanced relief options and expanding consumer choice globally.

The antacids industry is fragmented based on drug class, indication, dosage, route of administration, distribution channel, and region.

The acid neutralizers segment will observe a noteworthy surge through 2032, spurred by their immediate effectiveness in relieving heartburn and acid indigestion. These products, which include calcium carbonate and magnesium hydroxide, work by directly neutralizing stomach acid, providing rapid symptom relief. Their widespread availability over the counter and acceptance by consumers as a quick solution for digestive discomfort contribute to their dominant market position. The growing prevalence of gastroesophageal reflux disease (GERD) further boosts the demand for acid neutralizers.

The heartburn segment will undergo a remarkable upturn by 2032, owing to the widespread occurrence of this condition among adults. Heartburn, often caused by gastroesophageal reflux disease (GERD), drives a significant demand for over-the-counter antacids that provide quick and effective relief. The availability of various formulations, such as tablets, liquids, and chewables, caters to diverse consumer preferences, further boosting market growth. Also, increasing awareness about managing heartburn symptoms and the convenience of self-medication contribute to the segment's dominance.

Asia Pacific antacids market share will experience a notable CAGR from 2024 to 2032 due to the region's high prevalence of digestive disorders and growing healthcare awareness. Rapid urbanization, changing dietary habits, and increased stress levels contribute to the rising incidence of heartburn and acid reflux in countries like China and India. Besides, the expanding middle-class population and improved access to healthcare products are driving the demand for antacids. The region's growing focus on managing digestive health effectively positions Asia Pacific as a crucial contributor to the antacids industry. Show more